N.J. Gov. Murphy Signs Legislation Promoting Transparency on the New Jersey Drug Utilization Review Board
November 09, 2021
November 09, 2021
TRENTON, New Jersey, Nov. 9 -- Gov. Phil Murphy, D-New Jersey, issued the following news release on Nov. 8, 2021:
Governor Phil Murphy today signed legislation (A-277/S-2035) that requires public members of the New Jersey Drug Utilization Review Board to submit disclosures of financial interests and involvement in pharmaceutical distributors, manufacturers, or benefits managers. The bill continues the Murphy Administration's efforts to promote transparency and integrity in heal . . .
Governor Phil Murphy today signed legislation (A-277/S-2035) that requires public members of the New Jersey Drug Utilization Review Board to submit disclosures of financial interests and involvement in pharmaceutical distributors, manufacturers, or benefits managers. The bill continues the Murphy Administration's efforts to promote transparency and integrity in heal . . .